avram morrell (25 resultados)

Hardcover. Condición: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Condición: Fine. Estado de la sobrecubierta: Fine. First Edition. Collects 13 stories plus the editor's introduction. 219 pages, including Appendix A Shadows by Volume, Appendix B Shadows by Author. Fine copy in Fine jacket. clph.

Hardcover. Condición: Brand New. 264 pages. 9.00x6.00x1.00 inches. In Stock.

Condición: New. In.

Hardcover. Condición: Good. This book is in good condition only; study or reading copy only. The book has some shelfwear; light vertical bend to side edge from improper storage, so not a copy for collectors. Inside pages are clean. ; 372 pages.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: New. pp. 348.

Paperback. Condición: Brand New. reprint edition. 324 pages. 9.00x5.75x0.75 inches. In Stock.

Condición: Used. pp. 372.

Condición: Used. pp. 372.

Condición: Used. pp. 372.

Taschenbuch. Condición: Neu. Prevention of Kidney Disease and Long-Term Survival | Morrell M. Avram | Taschenbuch | 354 S. | Englisch | 2012 | Springer | EAN 9781468442014 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Renal Failure Prevention and Treatment in the 19808 It appears logical to juxtapose in this volume prevention-low cost and nonmorbid-with uremia therapy, which is very morbid and very high cost. Treated uremic patients constitute an important, complex, and demanding group of survivors of a formerly universally fatal disease. Throughout the developed nations of the world, an increasing fraction of the health care budget is devoted to sustaining lives by dialytic therapy and renal transplantation. In the United States, for example, patients in renal failure comprise 0.2% of those eligible for support by Medicare, but consume 5.0% of the Medicare budget. Economic stresses in funding kidney patients have, in some countries such as Great Britain, forced a return to restrictive selection policies abhorrent to empathetic physicians. For third world residents, attention to nutrition, sanitation, and infections such as malaria must take a higher priority than costly uremia therapy. Thus the solution of one problem (retarding death from uremia) created several equally vexing other dilemmas (who should be treated and at what cost ). While sociologists, economists, and ethicists struggle with the new field of psychonephrology,1 a group of investigators and clinicians convened to examine medical aspects of long-surviving treated uremic patients. These proceedings represent the first American analyis of those unique patients who have lived for ten or more years beyond what would have formerly been certain death in uremia.

Condición: New. Provides a summary of work in progress directed toward renoprotection and of ultimate interdiction of ESRD. This work is suitable for renal trainees, experienced kidney doctors, nurses, nutritionists and cardiologists. Editor(s): Avram, Morrell M. Num Pages: 134 pages, biography. BIC Classification: MJR. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 279 x 210 x 11. Weight in Grams: 493. . 2002. Hardback. . . . .

Hardcover. Condición: Brand New. 1st edition. 134 pages. 10.25x7.75x0.50 inches. In Stock.

Condición: New. Provides a summary of work in progress directed toward renoprotection and of ultimate interdiction of ESRD. This work is suitable for renal trainees, experienced kidney doctors, nurses, nutritionists and cardiologists. Editor(s): Avram, Morrell M. Num Pages: 134 pages, biography. BIC Classification: MJR. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 279 x 210 x 11. Weight in Grams: 493. . 2002. Hardback. . . . . Books ship from the US and Ireland.

Hardcover. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Hardcover. Condición: Very Good. Estado de la sobrecubierta: Very Good. 1st Edition. - Inspected, Cleaned, Sealed in Shrink Wrap - SIGNED by contributor William Nolan - FIRST EDITION - Archival Dust Jacket Cover - Tight Binding/Sharp Corners - Clean & Unmarked - Returns Accepted / Refunds Given Inspected, Cleaned & Sealed by me, the proprietor. SIGNED with a sketch by William Nolan at his story. 1991. 1st edition. Hardcover book with the dust jacket. Includes a New archival dust jacket cover. It has a tight binding with sharp corners. The text part of the book is clean and unmarked. 766 pages. 9.5" x 6.5". Sealed in Shrink Wrap for protection in storage and shipping. Expertly packed. *PROFESSIONAL BOOKSELLER* I try hard to get the descriptions right, sometimes I make a mistake, therefore, Returns accepted. Refunds given. -Gordon. Signed by Author(s).

Condición: new. Questo è un articolo print on demand.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Renal Failure Prevention and Treatment in the 19808 It appears logical to juxtapose in this volume prevention-low cost and nonmorbid-with uremia therapy, which is very morbid and very high cost. Treated uremic patients constitute an important, complex, and demanding group of survivors of a formerly universally fatal disease. Throughout the developed nations of the world, an increasing fraction of the health care budget is devoted to sustaining lives by dialytic therapy and renal transplantation. In the United States, for example, patients in renal failure comprise 0.2% of those eligible for support by Medicare, but consume 5.0% of the Medicare budget. Economic stresses in funding kidney patients have, in some countries such as Great Britain, forced a return to restrictive selection policies abhorrent to empathetic physicians. For third world residents, attention to nutrition, sanitation, and infections such as malaria must take a higher priority than costly uremia therapy. Thus the solution of one problem (retarding death from uremia) created several equally vexing other dilemmas (who should be treated and at what cost ). While sociologists, economists, and ethicists struggle with the new field of psychonephrology,1 a group of investigators and clinicians convened to examine medical aspects of long-surviving treated uremic patients. These proceedings represent the first American analyis of those unique patients who have lived for ten or more years beyond what would have formerly been certain death in uremia. 348 pp. Englisch.

Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Condición: New. Print on Demand pp. 348 23:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on White w/Gloss Lam.

Condición: New. PRINT ON DEMAND pp. 348.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Renal Failure Prevention and Treatment in the 19808 It appears logical to juxtapose in this volume prevention-low cost and nonmorbid-with uremia therapy, which is very morbid and very high cost. Treated uremic patients constitute an important, complex, and .

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Renal Failure Prevention and Treatment in the 19808 It appears logical to juxtapose in this volume prevention-low cost and nonmorbid-with uremia therapy, which is very morbid and very high cost. Treated uremic patients constitute an important, complex, and demanding group of survivors of a formerly universally fatal disease. Throughout the developed nations of the world, an increasing fraction of the health care budget is devoted to sustaining lives by dialytic therapy and renal transplantation. In the United States, for example, patients in renal failure comprise 0.2% of those eligible for support by Medicare, but consume 5.0% of the Medicare budget. Economic stresses in funding kidney patients have, in some countries such as Great Britain, forced a return to restrictive selection policies abhorrent to empathetic physicians. For third world residents, attention to nutrition, sanitation, and infections such as malaria must take a higher priority than costly uremia therapy. Thus the solution of one problem (retarding death from uremia) created several equally vexing other dilemmas (who should be treated and at what cost ). While sociologists, economists, and ethicists struggle with the new field of psychonephrology,1 a group of investigators and clinicians convened to examine medical aspects of long-surviving treated uremic patients. These proceedings represent the first American analyis of those unique patients who have lived for ten or more years beyond what would have formerly been certain death in uremia.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 348 pp. Englisch.